Kato Motohiro | Pre-clinical Research Dept. I Chugai Pharmaceutical Co. Ltd.
スポンサーリンク
概要
関連著者
-
Kato Motohiro
Pre-clinical Research Dept. I Chugai Pharmaceutical Co. Ltd.
-
Kato Motohiro
Pre-clinical Research Department Chugai Pharmaceutical Co. Ltd.
-
SUGIYAMA Yuichi
Graduate School of Pharmaceutical Sciences, The University of Tokyo
-
Sugiyama Yuichi
Graduate School Of Pharmaceutical Sciences The University Of Tokyo
-
Sugiyama Yuichi
Graduate School Of Pharmaceutical Sciences The Univ. Of Tokyo
-
Kato Motohiro
Pre-clinical Research Dept. Chugai Pharmaceutical Co. Ltd.
-
Sugiyama Yuichi
Graduate School of Industrial Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda-shi, Chiba 278-8510, Japan
-
Ito Kiyomi
Department of Clinical Pharmacokinetics, School of Pharmacy and Pharmaceutical Sciences, Hoshi Unive
-
OKAZAKI Osamu
Drug Metabolism & Physicochemistry Research Laboratory, R&D Division, Daiichi Pharmaceutical Co., Lt
-
ITO Kiyomi
School of Pharmaceutical Sciences, Kitasato University
-
UEDA Kaoru
Graduate School of Pharmaceutical Sciences, The University of Tokyo
-
Aso Yoshinori
Pre-clinical Research Dept. I Chugai Pharmaceutical Co. Ltd.
-
Aso Yoshinori
Fuji Gotemba Research Laboratories Chugai Pharmaceutical Company Ltd.
-
Ito Kiyomi
Department Of Clinical Pharmacokinetics Hoshi University
-
Ito Kiyomi
School Of Pharmaceutical Sciences Kitasato University
-
Tachibana Tatsuhiko
Pre-clinical Research Dept. I Chugai Pharmaceutical Co. Ltd.
-
Nabuchi Yoshiaki
Pre-clinical Research Dept. I Chugai Pharmaceutical Co. Ltd.
-
Nabuchi Yoshiaki
Fuji Gotemba Research Laboratories Chugai Pharmaceutical Company Ltd.
-
Ueda Kaoru
Graduate School Of Pharmaceutical Sciences The University Of Tokyo
-
Chiba Koji
Clinical Pharmacology Group Pfizer Japan Inc.
-
Kayama Makoto
Project Coordination Department Yamanouchi Pharmacentical Co. Ltd.
-
Kawanishi Takehiko
Pre-clinical Research Department Chugai Pharmaceutical Co. Ltd.
-
Mitsui Tetsuya
Pre-clinical Research Department Chugai Pharmaceutical Co. Ltd.
-
Nabuchi Yoshiaki
Pre-clinical Research Department Chugai Pharmaceutical Co. Ltd.
-
Aso Yoshinori
Pre-clinical Research Department Chugai Pharmaceutical Co. Ltd.
-
SEKIGUCHI Nobuo
Pre-Clinical Research Department, Chugai Pharmaceutical Co., Ltd.
-
HIGASHIDA Atsuko
Discovery Platform Technology Department, Chugai Pharmaceutical Co., Ltd.
-
TAKANASHI Kenji
Pre-Clinical Research Department, Chugai Pharmaceutical Co., Ltd.
-
ISHIGAI Masaki
Pre-Clinical Research Department, Chugai Pharmaceutical Co., Ltd.
-
Ishigai Masaki
Pre-clinical Research Department Chugai Pharmaceutical Co. Ltd.
-
Sekiguchi Nobuo
Pre-clinical Research Department Chugai Pharmaceutical Co. Ltd.
-
Takakuwa Susumu
Drug Metabolism And Pharmacokinetics Section Eisai Co. Ltd.
-
HISAKA Akihiro
Clinical Pharmacology & Development, Banyu Pharmaceutical Co. Ltd.
-
ISHIGAMI Michi
Clinical Pharmacology Department, Sankyo Co. Ltd.
-
MIZUNO Naomi
Pharmacokinetics Laboratory, Mitsubishi Pharma, Co., Ltd.
-
NAGATA Yoshinori
Pharmacokinetic Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
-
TSUKAMOTO Yuko
Planning & Control Department. Teikoku Hormone MFG. CO. Ltd.
-
Chiba Koji
Faculty Of Pharmacy Keio University
-
ITO Takashi
Drug Metabolism & Pharmacokinetics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd.
-
Mizuno Naomi
Pharmacokinetics Laboratory Mitsubishi Pharma Co. Ltd.
-
Ishigami Michi
Clinical Pharmacology Department Sankyo Co. Ltd.
-
Hisaka Akihiro
Clinical Pharmacology & Development Banyu Pharmaceutical Co. Ltd.
-
Tsukamoto Yuko
Planning & Control Department. Teikoku Hormone Mfg. Co. Ltd.
-
Okazaki Osamu
Drug Metabolism & Pharmacokinetics Research Laboratories R&d Division Daiichi Sankyo Co. Ltd
-
Nagata Yoshinori
Pharmacokinetic Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Higashida Atsuko
Discovery Platform Technology Department Chugai Pharmaceutical Co. Ltd.
-
KATO Motohiro
Pre-clinical Research Dept. I, Chugai Pharmaceutical Co. Ltd.
著作論文
- Evaluation of Methods for Prediciting Drug-drug Interactions by Monte Carlo Simulation
- Prediction of Drug-Drug Interactions based on Time-Dependent Inhibition from High Throughput Screening of Cytochrome P450 3A4 Inhibition
- The Intestinal First-pass Metabolism of Substrates of CYP3A4 and P-glycoprotein-Quantitative Analysis Based on Information from the Literature
- Intestinal First-Pass Metabolism of CYP3A4 Substrates
- Estimation of the Interindividual Variability of Cytochrome 2D6 Activity from Urinary Metabolic Ratios in the Literature